Evidence map›Paper›PMID 42565216›Full record

ReviewBiochemical Society transactions2026

Communication is key: combinatorial phosphorylation and functional cross-talk in the RNA polymerase II CTD code.

Y Jessie Zhang, Erin Ramsey

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Y Jessie ZhangDepartment of Molecular Biosciences, University of Texas, Austin.ORCID 0000-0002-9360-5388
Erin RamseyDepartment of Molecular Biosciences, University of Texas, Austin.

Funding

Deciphering the phosphorylation pattern of RNA polymerase II for eukaryotic transcriptionR35GM148356 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Yan Jessie Zhang · 2023 to 2026
$2.3M
HHS | NIH | National Institute of General Medical Sciences (NIGMS) R35GM148356HHS | NIH | NCI | Division of Cancer Prevention, National Cancer Institute (DCP, NCI) R01CA381106NIGMS NIH HHS R35 GM148356
6 · The paper itself

Abstract

The C-terminal domain (CTD) of the largest subunit of RNA polymerase II serves as a dynamic platform coordinating transcription and RNA processing. Recent advances in mass spectrometry, structural biology, and sequencing approaches have revealed a far more complex, combinatorial CTD code than previously appreciated. The present review examines the CTD as an integrative signaling hub that translates diverse environmental signals into genomic outputs. We explore the hierarchical transitions between phosphorylation states, highlighting how combinatorial marks rather than isolated modifications shape transcriptional progression and prevent cryptic initiation through cross-talk with the histone code. Special focus is given to the roles of 'enigmatic' marks such as pTyr1 and pThr4, whose functional significance has been complicated by biochemical masking effects and species-specific regulatory nodes. We also discuss emerging evidence that CTD remodeling contributes to stress-responsive transcription, including oxidative stress, heat shock, and DNA damage. Together, these observations support a dynamic model of the CTD in which combinatorial phosphorylation states coordinate transcriptional progression, genome stability, and stress-responsive gene regulation.

Indexed as

RNA Polymerase IIAnimalsHumansPhosphorylationProtein DomainsSignal TransductionTranscription, GeneticRNA Polymerase IICombinatorial PTM CodeEpitope MaskingRNA Polymerase II CTDTranscription Elongation

Identifiers

PMID42565216
PMCPMC13451535

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.